William H Herman, Thomas J Hoerger, Michael Brandle, Katherine Hicks, Stephen Sorensen, Ping Zhang, Richard F Hamman, Ronald T Ackermann, Michael M Engelgau, Robert E Ratner. Ann Intern Med 2005
Times Cited: 457
Times Cited: 457
Times Cited
Times Co-cited
Similarity
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
55
The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.
. Diabetes Care 2012
. Diabetes Care 2012
26
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
William C Knowler, Sarah E Fowler, Richard F Hamman, Costas A Christophi, Heather J Hoffman, Anne T Brenneman, Janet O Brown-Friday, Ronald Goldberg, Elizabeth Venditti, David M Nathan. Lancet 2009
William C Knowler, Sarah E Fowler, Richard F Hamman, Costas A Christophi, Heather J Hoffman, Anne T Brenneman, Janet O Brown-Friday, Ronald Goldberg, Elizabeth Venditti, David M Nathan. Lancet 2009
24
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
22
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
. Lancet Diabetes Endocrinol 2015
. Lancet Diabetes Endocrinol 2015
20
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).
A Ramachandran, C Snehalatha, S Mary, B Mukesh, A D Bhaskar, V Vijay. Diabetologia 2006
A Ramachandran, C Snehalatha, S Mary, B Mukesh, A D Bhaskar, V Vijay. Diabetologia 2006
20
Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
. Diabetes Care 2003
. Diabetes Care 2003
19
Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.
Rui Li, Shuli Qu, Ping Zhang, Sajal Chattopadhyay, Edward W Gregg, Ann Albright, David Hopkins, Nicolaas P Pronk. Ann Intern Med 2015
Rui Li, Shuli Qu, Ping Zhang, Sajal Chattopadhyay, Edward W Gregg, Ann Albright, David Hopkins, Nicolaas P Pronk. Ann Intern Med 2015
19
15
Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.
Jaana Lindström, Pirjo Ilanne-Parikka, Markku Peltonen, Sirkka Aunola, Johan G Eriksson, Katri Hemiö, Helena Hämäläinen, Pirjo Härkönen, Sirkka Keinänen-Kiukaanniemi, Mauri Laakso,[...]. Lancet 2006
Jaana Lindström, Pirjo Ilanne-Parikka, Markku Peltonen, Sirkka Aunola, Johan G Eriksson, Katri Hemiö, Helena Hämäläinen, Pirjo Härkönen, Sirkka Keinänen-Kiukaanniemi, Mauri Laakso,[...]. Lancet 2006
14
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
X R Pan, G W Li, Y H Hu, J X Wang, W Y Yang, Z X An, Z X Hu, J Lin, J Z Xiao, H B Cao,[...]. Diabetes Care 1997
X R Pan, G W Li, Y H Hu, J X Wang, W Y Yang, Z X An, Z X Hu, J Lin, J Z Xiao, H B Cao,[...]. Diabetes Care 1997
13
Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.
Ethan M Balk, Amy Earley, Gowri Raman, Esther A Avendano, Anastassios G Pittas, Patrick L Remington. Ann Intern Med 2015
Ethan M Balk, Amy Earley, Gowri Raman, Esther A Avendano, Anastassios G Pittas, Patrick L Remington. Ann Intern Med 2015
12
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
Guangwei Li, Ping Zhang, Jinping Wang, Edward W Gregg, Wenying Yang, Qiuhong Gong, Hui Li, Hongliang Li, Yayun Jiang, Yali An,[...]. Lancet 2008
Guangwei Li, Ping Zhang, Jinping Wang, Edward W Gregg, Wenying Yang, Qiuhong Gong, Hui Li, Hongliang Li, Yayun Jiang, Yali An,[...]. Lancet 2008
12
How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?
Mohammed K Ali, Justin Echouffo-Tcheugui, David F Williamson. Health Aff (Millwood) 2012
Mohammed K Ali, Justin Echouffo-Tcheugui, David F Williamson. Health Aff (Millwood) 2012
12
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
Guangwei Li, Ping Zhang, Jinping Wang, Yali An, Qiuhong Gong, Edward W Gregg, Wenying Yang, Bo Zhang, Ying Shuai, Jing Hong,[...]. Lancet Diabetes Endocrinol 2014
Guangwei Li, Ping Zhang, Jinping Wang, Yali An, Qiuhong Gong, Edward W Gregg, Wenying Yang, Bo Zhang, Ying Shuai, Jing Hong,[...]. Lancet Diabetes Endocrinol 2014
12
Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
David M Eddy, Leonard Schlessinger, Richard Kahn. Ann Intern Med 2005
David M Eddy, Leonard Schlessinger, Richard Kahn. Ann Intern Med 2005
11
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.
V R Aroda, C A Christophi, S L Edelstein, P Zhang, W H Herman, E Barrett-Connor, L M Delahanty, M G Montez, R T Ackermann, X Zhuo,[...]. J Clin Endocrinol Metab 2015
V R Aroda, C A Christophi, S L Edelstein, P Zhang, W H Herman, E Barrett-Connor, L M Delahanty, M G Montez, R T Ackermann, X Zhuo,[...]. J Clin Endocrinol Metab 2015
11
A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program.
Elizabeth K Ely, Stephanie M Gruss, Elizabeth T Luman, Edward W Gregg, Mohammed K Ali, Kunthea Nhim, Deborah B Rolka, Ann L Albright. Diabetes Care 2017
Elizabeth K Ely, Stephanie M Gruss, Elizabeth T Luman, Edward W Gregg, Mohammed K Ali, Kunthea Nhim, Deborah B Rolka, Ann L Albright. Diabetes Care 2017
11
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
11
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
Qiuhong Gong, Ping Zhang, Jinping Wang, Jixiang Ma, Yali An, Yanyan Chen, Bo Zhang, Xinxing Feng, Hui Li, Xiaoping Chen,[...]. Lancet Diabetes Endocrinol 2019
Qiuhong Gong, Ping Zhang, Jinping Wang, Jixiang Ma, Yali An, Yanyan Chen, Bo Zhang, Xinxing Feng, Hui Li, Xiaoping Chen,[...]. Lancet Diabetes Endocrinol 2019
11
Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study.
Ronald T Ackermann, Emily A Finch, Edward Brizendine, Honghong Zhou, David G Marrero. Am J Prev Med 2008
Ronald T Ackermann, Emily A Finch, Edward Brizendine, Honghong Zhou, David G Marrero. Am J Prev Med 2008
10
Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.
Robert E Ratner, Costas A Christophi, Boyd E Metzger, Dana Dabelea, Peter H Bennett, Xavier Pi-Sunyer, Sarah Fowler, Steven E Kahn. J Clin Endocrinol Metab 2008
Robert E Ratner, Costas A Christophi, Boyd E Metzger, Dana Dabelea, Peter H Bennett, Xavier Pi-Sunyer, Sarah Fowler, Steven E Kahn. J Clin Endocrinol Metab 2008
10
Prediabetes: a high-risk state for diabetes development.
Adam G Tabák, Christian Herder, Wolfgang Rathmann, Eric J Brunner, Mika Kivimäki. Lancet 2012
Adam G Tabák, Christian Herder, Wolfgang Rathmann, Eric J Brunner, Mika Kivimäki. Lancet 2012
10
Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.
. Diabetes Care 2012
. Diabetes Care 2012
9
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
H C Gerstein, S Yusuf, J Bosch, J Pogue, P Sheridan, N Dinccag, M Hanefeld, B Hoogwerf, M Laakso, V Mohan,[...]. Lancet 2006
H C Gerstein, S Yusuf, J Bosch, J Pogue, P Sheridan, N Dinccag, M Hanefeld, B Hoogwerf, M Laakso, V Mohan,[...]. Lancet 2006
9
Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.
William H Herman, Sharon L Edelstein, Robert E Ratner, Maria G Montez, Ronald T Ackermann, Trevor J Orchard, Mary A Foulkes, Ping Zhang, Christopher D Saudek, Morton B Brown. Am J Manag Care 2013
William H Herman, Sharon L Edelstein, Robert E Ratner, Maria G Montez, Ronald T Ackermann, Trevor J Orchard, Mary A Foulkes, Ping Zhang, Christopher D Saudek, Morton B Brown. Am J Manag Care 2013
14
Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP).
Ambady Ramachandran, Chamukuttan Snehalatha, Annasami Yamuna, Simon Mary, Zhang Ping. Diabetes Care 2007
Ambady Ramachandran, Chamukuttan Snehalatha, Annasami Yamuna, Simon Mary, Zhang Ping. Diabetes Care 2007
9
Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
J Sonya Haw, Karla I Galaviz, Audrey N Straus, Alysse J Kowalski, Matthew J Magee, Mary Beth Weber, Jingkai Wei, K M Venkat Narayan, Mohammed K Ali. JAMA Intern Med 2017
J Sonya Haw, Karla I Galaviz, Audrey N Straus, Alysse J Kowalski, Matthew J Magee, Mary Beth Weber, Jingkai Wei, K M Venkat Narayan, Mohammed K Ali. JAMA Intern Med 2017
9
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.
Yuli Huang, Xiaoyan Cai, Weiyi Mai, Meijun Li, Yunzhao Hu. BMJ 2016
Yuli Huang, Xiaoyan Cai, Weiyi Mai, Meijun Li, Yunzhao Hu. BMJ 2016
9
Effect of weight loss with lifestyle intervention on risk of diabetes.
Richard F Hamman, Rena R Wing, Sharon L Edelstein, John M Lachin, George A Bray, Linda Delahanty, Mary Hoskin, Andrea M Kriska, Elizabeth J Mayer-Davis, Xavier Pi-Sunyer,[...]. Diabetes Care 2006
Richard F Hamman, Rena R Wing, Sharon L Edelstein, John M Lachin, George A Bray, Linda Delahanty, Mary Hoskin, Andrea M Kriska, Elizabeth J Mayer-Davis, Xavier Pi-Sunyer,[...]. Diabetes Care 2006
9
Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review.
Rui Li, Ping Zhang, Lawrence E Barker, Farah M Chowdhury, Xuanping Zhang. Diabetes Care 2010
Rui Li, Ping Zhang, Lawrence E Barker, Farah M Chowdhury, Xuanping Zhang. Diabetes Care 2010
8
Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards.
S Cameron Sepah, Luohua Jiang, Anne L Peters. Diabetes Educ 2014
S Cameron Sepah, Luohua Jiang, Anne L Peters. Diabetes Educ 2014
10
Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program.
Ann L Albright, Edward W Gregg. Am J Prev Med 2013
Ann L Albright, Edward W Gregg. Am J Prev Med 2013
8
Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model.
Ronald T Ackermann, David G Marrero. Diabetes Educ 2007
Ronald T Ackermann, David G Marrero. Diabetes Educ 2007
8
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.
William H Hernan, Michael Brandle, Ping Zhang, David F Williamson, Margaret J Matulik, Robert E Ratner, John M Lachin, Michael M Engelgau. Diabetes Care 2003
William H Hernan, Michael Brandle, Ping Zhang, David F Williamson, Margaret J Matulik, Robert E Ratner, John M Lachin, Michael M Engelgau. Diabetes Care 2003
8
Cardiometabolic Risk Factor Changes Observed in Diabetes Prevention Programs in US Settings: A Systematic Review and Meta-analysis.
Uma Mudaliar, Azadeh Zabetian, Michael Goodman, Justin B Echouffo-Tcheugui, Ann L Albright, Edward W Gregg, Mohammed K Ali. PLoS Med 2016
Uma Mudaliar, Azadeh Zabetian, Michael Goodman, Justin B Echouffo-Tcheugui, Ann L Albright, Edward W Gregg, Mohammed K Ali. PLoS Med 2016
10
Pioglitazone for diabetes prevention in impaired glucose tolerance.
Ralph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, George A Bray, Thomas A Buchanan, Stephen C Clement, Robert R Henry, Howard N Hodis, Abbas E Kitabchi,[...]. N Engl J Med 2011
Ralph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, George A Bray, Thomas A Buchanan, Stephen C Clement, Robert R Henry, Howard N Hodis, Abbas E Kitabchi,[...]. N Engl J Med 2011
8
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
Carel W le Roux, Arne Astrup, Ken Fujioka, Frank Greenway, David C W Lau, Luc Van Gaal, Rafael Violante Ortiz, John P H Wilding, Trine V Skjøth, Linda Shapiro Manning,[...]. Lancet 2017
Carel W le Roux, Arne Astrup, Ken Fujioka, Frank Greenway, David C W Lau, Luc Van Gaal, Rafael Violante Ortiz, John P H Wilding, Trine V Skjøth, Linda Shapiro Manning,[...]. Lancet 2017
8
XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.
Jarl S Torgerson, Jonathan Hauptman, Mark N Boldrin, Lars Sjöström. Diabetes Care 2004
Jarl S Torgerson, Jonathan Hauptman, Mark N Boldrin, Lars Sjöström. Diabetes Care 2004
8
Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.
Samantha Roberts, Eleanor Barry, Dawn Craig, Mara Airoldi, Gwyn Bevan, Trisha Greenhalgh. BMJ Open 2017
Samantha Roberts, Eleanor Barry, Dawn Craig, Mara Airoldi, Gwyn Bevan, Trisha Greenhalgh. BMJ Open 2017
18
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.
Q Gong, E W Gregg, J Wang, Y An, P Zhang, W Yang, H Li, H Li, Y Jiang, Y Shuai,[...]. Diabetologia 2011
Q Gong, E W Gregg, J Wang, Y An, P Zhang, W Yang, H Li, H Li, Y Jiang, Y Shuai,[...]. Diabetologia 2011
7
Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.
Thomas J Hoerger, Katherine A Hicks, Stephen W Sorensen, William H Herman, Robert E Ratner, Ronald T Ackermann, Ping Zhang, Michael M Engelgau. Diabetes Care 2007
Thomas J Hoerger, Katherine A Hicks, Stephen W Sorensen, William H Herman, Robert E Ratner, Ronald T Ackermann, Ping Zhang, Michael M Engelgau. Diabetes Care 2007
8
Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
A J Palmer, D M D Tucker. Prim Care Diabetes 2012
A J Palmer, D M D Tucker. Prim Care Diabetes 2012
21
Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.
Albert L Siu. Ann Intern Med 2015
Albert L Siu. Ann Intern Med 2015
7
Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.
Ryuzo Kawamori, Naoko Tajima, Yasuhiko Iwamoto, Atsunori Kashiwagi, Kazuaki Shimamoto, Kohei Kaku. Lancet 2009
Ryuzo Kawamori, Naoko Tajima, Yasuhiko Iwamoto, Atsunori Kashiwagi, Kazuaki Shimamoto, Kohei Kaku. Lancet 2009
7
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
Peter J Neumann, Joshua T Cohen, Milton C Weinstein. N Engl J Med 2014
Peter J Neumann, Joshua T Cohen, Milton C Weinstein. N Engl J Med 2014
7
Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis.
Alison J Dunkley, Danielle H Bodicoat, Colin J Greaves, Claire Russell, Thomas Yates, Melanie J Davies, Kamlesh Khunti. Diabetes Care 2014
Alison J Dunkley, Danielle H Bodicoat, Colin J Greaves, Claire Russell, Thomas Yates, Melanie J Davies, Kamlesh Khunti. Diabetes Care 2014
6
Exercise and insulin resistance in youth: a meta-analysis.
Michael V Fedewa, Nicholas H Gist, Ellen M Evans, Rod K Dishman. Pediatrics 2014
Michael V Fedewa, Nicholas H Gist, Ellen M Evans, Rod K Dishman. Pediatrics 2014
7
Breaks in sedentary time: beneficial associations with metabolic risk.
Genevieve N Healy, David W Dunstan, Jo Salmon, Ester Cerin, Jonathan E Shaw, Paul Z Zimmet, Neville Owen. Diabetes Care 2008
Genevieve N Healy, David W Dunstan, Jo Salmon, Ester Cerin, Jonathan E Shaw, Paul Z Zimmet, Neville Owen. Diabetes Care 2008
6
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.